Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1991; 18:937-943
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winters, S.
Right arrow Articles by Gomes, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winters, S.
Right arrow Articles by Gomes, J.

Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device

SL Winters, M Cohen, S Greenberg, B Stein, J Curwin, E Pe, and JA Gomes

Department of Medicine, Mount Sinai School of Medicine, City University of New York, New York 10029.

The presentation, cardiac anatomy and utility of programmed ventricular stimulation in seven patients with sustained ventricular tachycardia associated with sarcoidosis are described. The mean patient age was 38 +/- 8 years. Pulmonary involvement was apparent in three patients and no systemic manifestations of sarcoidosis were present in one patient. All patients had electrocardiographic abnormalities at rest and six had a left ventricular ejection fraction less than 45%. All seven patients had left ventricular wall motion abnormalities and five had mitral valve dysfunction. Sustained ventricular tachycardia was easily induced in all patients. Spontaneous sustained ventricular tachycardia was not prevented with corticosteroid administration. Despite antiarrhythmic drug therapy, two patients had sudden cardiac death and an additional four had recurrence of ventricular tachycardia. Four patients had an automatic cardioverter-defibrillator implanted and received drug therapy; all four received appropriate shocks. This report represents the largest descriptive series of consecutive patients with sustained ventricular tachycardia associated with sarcoidosis. Antiarrhythmic drug therapy of ventricular tachycardia in patients with sarcoidosis, even when guided with programmed ventricular stimulation, is associated with a high rate of arrhythmia recurrence or sudden death, or both. Thus, implantation of an automatic antitachycardia device (cardioverter-defibrillator) should be considered as primary therapy in such patients. Furthermore, sarcoidosis should be excluded, with Kveim skin testing if necessary, in any patient with sustained ventricular tachycardia of unknown origin.


This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
D. Mehta, N. Mori, S. H. Goldbarg, S. Lubitz, J. P. Wisnivesky, and A. Teirstein
Primary Prevention of Sudden Cardiac Death in Silent Cardiac Sarcoidosis: Role of Programmed Ventricular Stimulation
Circ Arrhythm Electrophysiol, February 1, 2011; 4(1): 43 - 48.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. K. Lakdawala and M. M. Givertz
Dilated Cardiomyopathy With Conduction Disease and Arrhythmia
Circulation, August 3, 2010; 122(5): 527 - 534.
[Full Text] [PDF]


Home page
Interstitial Lung DiseasesHome page
J. C. Grutters, M. Drent, and J. M. M. van Den Bosch
Sarcoidosis
Interstitial Lung Diseases, June 1, 2010; 126 - 154.
[Abstract] [Fulltext] [PDF]


Home page
Cleveland Clinic Journal of MedicineHome page
A. M. McDIVIT and A. T. ASKARI
A middle-aged man with progressive fatigue
Cleveland Clinic Journal of Medicine, October 1, 2009; 76(10): 564 - 574.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Myerburg, V. Reddy, and A. Castellanos
Indications for Implantable Cardioverter-Defibrillators Based on Evidence and Judgment
J. Am. Coll. Cardiol., August 25, 2009; 54(9): 747 - 763.
[Abstract] [Full Text] [PDF]


Home page
BMJ Case ReportsHome page
F. Mehrhof, M. Stockburger, H. Schuette, W. Haverkamp, and R. Dietz
Ventricular tachycardia as the first manifestation of cardiac sarcoidosis
BMJ Case Reports, April 28, 2009; 2009(apr23_1): bcr0820080810 - bcr0820080810.
[Abstract] [Full Text]


Home page
EuropaceHome page
P. Uusimaa, K. Ylitalo, O. Anttonen, T. Kerola, V. Virtanen, E. Paakko, and P. Raatikainen
Ventricular tachyarrhythmia as a primary presentation of sarcoidosis
Europace, June 1, 2008; 10(6): 760 - 766.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
Eur. Heart J., December 2, 2007; 28(24): 3076 - 3093.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology
J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1914 - 1931.
[Full Text] [PDF]


Home page
CirculationHome page
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Circulation, November 6, 2007; 116(19): 2216 - 2233.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
HeartHome page
A. R Doughan and B. R Williams
Cardiac sarcoidosis
Heart, February 1, 2006; 92(2): 282 - 288.
[Full Text] [PDF]


Home page
CirculationHome page
S. Nazarian, D. A. Bluemke, A. C. Lardo, M. M. Zviman, S. P. Watkins, T. L. Dickfeld, G. R. Meininger, A. Roguin, H. Calkins, G. F. Tomaselli, et al.
Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy
Circulation, November 1, 2005; 112(18): 2821 - 2825.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Heath, H Deubner, E J Stern, J E Cooke, and E A Gill
A 28 year old woman with ventricular tachycardia and an abnormal chest radiograph
Heart, June 1, 2003; 89(6): e19 - 19.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement